Serum CA19-9 Measurement Increases the Effectiveness of Staging Laparoscopy in Patients with Suspected Pancreatic Malignancy

By  

Digestive Surgery, Vol. 22, Iss. 1-2, 2005-05 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer

By Öge Ömer   Atsü Necmettin   Kendi Sezer   Özen Haluk  

International Urology and Nephrology, Vol. 32, Iss. 3, 2001-09 ,pp. : 367-370

Springer Publishing Company

Access to resources Recommend Favorite

Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker

By Melissourgos N.   Kastrinakis N.G.   Davilas I.   Foukas P.   Farmakis A.   Lykourinas M.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 362-367

Elsevier

Access to resources Recommend Favorite

Laparoscopic Splenic Total Cystectomy in a Patient With Elevated CA 19–9

By Paksoy Melih   Karabicak Ilhan   Kusaslan Ramazan   Demiryas Suleyman   Ayan Fadil   Ertem Metin  

JSLS, Journal of the Society of Laparoendoscopic Surgeons, Vol. 10, Iss. 4, 2006-10 ,pp. : 507-510

Society of Laparoendoscopic Surgeons

Access to resources Recommend Favorite

Is a Raised CA 19-9 Level Diagnostic for a Cholangiocarcinoma in Patients with No History of Sclerosing Cholangitis ?

By  

Digestive Surgery, Vol. 23, Iss. 5-6, 2007-02 ,pp. : 319-324

Karger

Access to resources Recommend Favorite